Siemens Healthineers · 14 hours ago
R&D Leadership Development Program - Assay Development
Tarrytown, NY
Full-time
Onsite
New GradSiemens Healthineers is a leading global healthcare company focused on pioneering breakthroughs in healthcare. They are offering a two-year rotational R&D Leadership Development Program for Laboratory Diagnostics that prepares participants for a career in Assay Development through diverse technical and leadership experiences.
Health CareHealth DiagnosticsMedicalMedical Device
No H1B
Responsibilities
Reagent Synthesis
Leading teams
Structured problem solving
Chemistry and Immunoassay development
Systems Integration
Verification Testing
Validation Testing
Project Management
In Vitro Diagnostic Assay and Calibrator Development for automated analyzers
Synthetic Organic Chemistry
Reagent Characterization
Chemical Database Building
Reagent Optimization and Troubleshooting
Design Control and Design Transfer to Manufacturing
Systems Integration
Product Support
Design control regulated activities such as risk management, design verification, design change, process characterization and validation
Troubleshooting
Analytical Techniques
Qualification
Required
Assay Development track majors (education level - PhD): Organic Chemistry, Biochemistry, Analytical Chemistry, Bioinformatics, Biophysics, Physical Chemistry, Chemical Engineering, or similar
Graduation date: Must graduate by the program start date, but no more than one year prior; program start date June 2026
Willingness to relocate between rotations. Potential locations include but are not limited to Tarrytown, NY, Newark, DE, and Walpole, MA
Work Authorization: Permanent work authorization in the U.S. is required
Preferred
Preferred GPA: 3.4
Company
Siemens Healthineers
Siemens Healthineers is a healthcare technology company that provides diagnostic and therapeutic products and services. It is a sub-organization of Siemens.
Founded in 1847
10001+ employees
Funding
Current Stage
Public CompanyTotal Funding
$2.76BKey Investors
Ontario Together Fund
2021-05-25Grant· $2.5M
2021-03-25Post Ipo Equity· $2.76B
2018-03-16IPO
Leadership Team
Enno Nehrbass
SVP / Head of Strategy & Collaboration Mgmt Diagnostic Imaging
Anton Ebert
Senior Technology Manager
Recent News
2026-01-21
Company data provided by crunchbase